Skizofrénia: vizsgálatok itt: Horvátország
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEvenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics
- Where
- Grad Zagreb
- Életkor
- 18 év and over
- People
- 135 worldwide
- Run by
- Newron Pharmaceuticals S.p.A.
See details and how to join2024-519836-18-00 · EU 2024-519836-18-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Where
- Zagreb
- Életkor
- 55 év and over
- People
- 370 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT06540833 - 3. fázisTaking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Grad Zagreb, Zagreb
- Életkor
- 55 év to 90 év
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - 2. fázisTaking peopleEvaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
- Where
- Grad Zagreb
- Életkor
- 18 év to 55 év
- People
- 120 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07288333 · EU 2025-521868-35-00 - 1. fázisNot yet taking people in HorvátországA Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 and the Relative Bioavailability at Steady-State of LY03010 versus XEPLION® in Patients with Schizophrenia
- Where
- Grad Zagreb, Split
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- Geneora Pharma (Shijiazhuang) Co. Ltd.
See details and how to join2023-508981-13-00 · EU 2023-508981-13-00